🇺🇸 FDA
Patent

US 10160745

Piperidine and azepine derivatives as prokineticin receptor modulators

granted A61KA61K31/454A61K31/4545

Quick answer

US patent 10160745 (Piperidine and azepine derivatives as prokineticin receptor modulators) held by Takeda Pharmaceutical Company Limited expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Dec 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K31/454, A61K31/4545, A61K31/501, A61K31/55